Health
COVID-19: Patients improve after immune-suppressant treatment – Medical Xpress
Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug Administration-approved drug normally given for rheumatoid arthritis, according to an observational study at Cedars-Sinai. Outcomes for pa…
Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug Administration-approved drug normally given for rheumatoid arthritis, according to an observational study at Cedars-Sinai. Outcomes for patients who received the drug, tocilizumab, included reduced inflammation, oxygen requirements, blood pressure support and risk of death, compared with published reports of illness and death associated with severely ill COVID-19 patients.
Th…
-
General23 hours agoMelbourne lawyer fled Australia with $1.2m after filing for bankruptcy, court case alleges
-
Noosa News19 hours agoMaroons name Gehamat Shibasaki for State of Origin debut against Blues, Josh Papali’i returns
-
Business19 hours agoShould I sell my loss-making stocks today?
-
Business20 hours agoCan the Xero share price deliver a 17% return after the US acquisition?